View Author
cancer study breast tumor patient association breast cancer breast cancer risk factor subtype tumor subtypes case patients table university lamivudine department interferon status receptor 1.00 analyses hbeag treatment institute research women hospital risk factors tumor characteristics hepatitis combination grade characteristic control expression analysis epidemiology seroconversion case –case analyses ratio 1/her survival case –control analyses genetic marker center 8 q 24 body mass index therapy hbeag seroconversion rate monotherapy heterogeneity pathology medicine germany estrogen diagnosis lamivudine monotherapy article breast cancer res difference –control variant hepatitis b pr 1/her combination therapy rs 2981582 family history hbeag seroconversion er-positive estimate obesity hormone family oncology estrogen receptor full-term birth per-allele triple-negative centre
4 Most Recent Publications
|
Associations of breast cancer risk factors with tumor subtypes: A pooled analysis from the breast cancer association consortium studies
(Article)
Yang, X.R. Chang-Claude, J. Fasching, P.A. Shen, C.-Y. Hsiung, C.-N. Wu, P.E. Yu, J.-C. Chen, S.-T. Hsu, G.-C. Haiman, C.A. Henderson, B.E. Le Marchand, L. Kolonel, L.N. Hein, R. Lindblom, A. Margolin, S. Jakubowska, A. Lubinski, J. Huzarski, T. Byrski, T. Górski, B. Gronwald, J. Hooning, M. Hollestelle, A. Spurdle, A.B. Ouweland, A.M.W. van den Jager, A. Kriege, M. Tilanus-Linthorst, M.M.A. Collee, J.M. Wang-Gohrke, S. Pylkäs, K. Jukkola-Vuorinen, A. Mononen, K. Grip, M. Blows, F. Hirvikoski, P. Winqvist, R. Mannermaa, A. Kosma, V.M. Kauppinen, J. Kataja, V. Auvinen, P. Soini, Y. Sironen, R. Bojesen, S.E. Driver, K. Dynnes Ørsted, D. Kaur-Knudsen, D. Flyger, H. Nordestgaard, B.G. Holland, H. Chenevix-Trench, G. Manoukian, S. Barile, M. Radice, P. Hankinson, S.E. Flesch-Janys, D. Hunter, D. Tamimi, R. Sangrajrang, S. Brennan, P. McKay, J. Odefrey, F. Gaborieau, V. Devilee, P. Huijts, P. Tollenaar, R. Heinz, J. Seynaeve, C.M. Dite, G.S. Apicella, C. Hopper, J. Hammet, F. Tsimiklis, H. Smith, L. Southey, M.C. Easton, D.F. Pharoah, P. Sinn, P. Sherman, M. García-Closas, M. Vrieling, A. Heikinen, T. Goode, E.L. Aittomäki, K. Heikkilä, P. Blomqvist, C. Lissowska, J. Peplonska, B. Chanock, S.J. Figueroa, J. Brinton, L.A. Hall, A.S. Czene, k. Couch, F.J. Humphreys, M.K. Darabi, H. Liu, J. Veer, L.J. van 't Leeuwen, F.E. van Andrulis, I.L. Glendon, G. Knight, J.A. Mulligan, A.M. O'Malley, F.P. Nevanlinna, H. Weerasooriya, N. John, E.M. Beckmann, M.W. Hartmann, A. Weihbrecht, S.B. Wachter, D.L. Jud, S.M. Loehberg, C.R. Baglietto, L. English, D.R. Milne, R.L. Giles, G.G. McLean, C.A. Severi, G. Lambrechts, D. Vandorpe, T. Weltens, C. Paridaens, R. Smeets, A. Neven, P. Wildiers, H. Gaudet, M.M. Wang, X. Olson, J.E. Cafourek, V. Fredericksen, Z. Kosel, M. Vachon, C. Cramp, H.E. Connley, D. Cross, S.S. Balasubramanian, S. Schmidt, M.K. Reed, M.W.R. Dörk, T. Bremer, M. Meyer, A. Karstens, J.H. Ay, A. Park-Simon, T.-W. Hillemanns, P. Arias Pérez, J.I. Rodríguez, P.M. Broeks, A. Zamora, P. Benitez, J. Ko, Y.D. Fischer, H.-P. Hamann, U. Pesch, B. Brüning, T. Justenhoven, C. Brauch, H. Eccles, D. Cox, A. Tapper, W. Gerty, S.M. Sawyer, E.J. Tomlinson, I.P. Jones, A. Kerin, M. Miller, N. McInerney, N. Anton-Culver, H. Ziogas, A. |
2011-02-02
|
|
Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival
(Article)
Azzato, E.M. Tyrer, J.P. Arias, J.I. Menéndez, P. Benítez, J. Chang-Claude, J. Hein, R. Wang-Gohrke, S. Nevanlinna, H. Heikinen, T. Aittomäki, K. Blomqvist, C. Fasching, P.A. Margolin, S. Mannermaa, A. Kosma, V.M. Kataja, V. Beesley, J. Chenevix-Trench, G. Couch, F.J. Olson, J.E. Fredericksen, Z. Wang, X. Beckmann, M.W. Giles, G.G. Severi, G. Baglietto, L. Southey, M.C. Devilee, P. Tollenaar, R.A.E.M. Seynaeve, C.M. García-Closas, M. Lissowska, J. Sherman, M. Ekici, A.B. Bolton, K.L. Hall, A.S. Czene, k. Cox, A. Brock, I.W. Elliott, G. Reed, M.W.R. Greenberg, D. Anton-Culver, H. Ziogas, A. Schulz-Wendtland, R. Humphreys, M.K. Easton, D.F. Caporaso, N.E. Pharoah, P.D.P. Bojesen, S.E. Nordestgaard, B.G. Flyger, H. Milne, R.L. |
2010-05-01
|
|
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics
(Article)
García-Closas, M. Hall, P. Milne, R.L. Brennan, P. McKay, J.D. Odefrey, F. Gabrieau, V. Sigurdson, A.J. Doody, M. Struewing, J.P. Alexander, B.H. Easton, D.F. Pharoah, P.D.P. Ribas, G. González-Neira, A. Benítez, J. Zamora, P. Brauch, H. Justenhoven, C. Hamann, U. Ko, Y.D. Bruening, T. Nevanlinna, H. Haas, S. Dörk, T. Schürmann, P. Hillemanns, P. Bogdanova, N.V. Bremer, M. Karstens, J.H. Fagerholm, R. Aaltonen, K. Aittomäki, K. Pooley, K.A. Smitten, K. von Blomqvist, C. Mannermaa, A. Uusitupa, M. Eskelinen, M. Tengström, M. Kosma, V.M. Kataja, V. Chenevix-Trench, G. Spurdle, A.B. Morrison, J. Beesley, J. Chen, X. Devilee, P. Asperen, C.J. van Jacobi, C.E. Tollenaar, R.A.E.M. Huijts, P. Klijn, J.G.M. Chang-Claude, J. Kropp, S. Richesson, D.A. Slanger, T. Flesch-Janys, D. Mutschelknauss, E. Salazar, R. Wang-Gohrke, S. Couch, F.J. Goode, E.L. Olson, J.E. Vachon, C. Fredericksen, Z. Bojesen, S.E. Giles, G.G. Baglietto, L. Severi, G. Hopper, J.L. English, D.R. Southey, M.C. Haiman, C.A. Henderson, B.E. Kolonel, L.N. Le Marchand, L. Nordestgaard, B.G. Stram, D.O. Hunter, D. Hankinson, S.E. Cox, A. Tamimi, R. Kraft, P. Sherman, M. Chanock, S.J. Lissowska, J. Brinton, L.A. Axelsson, C.K. Peplonska, B. Hooning, M. Meijers-Heijboer, E.J. Collee, J.M. Ouweland, A.M.W. van den Uitterlinden, A.G. Liu, J. Low, Y.L. Yuqing, L. Humphreys, M.K. Arias, J.I. Czene, k. Balasubramanian, S. Cross, S.S. Reed, M.W.R. Blows, F. Driver, K. Dunning, A.M. Tyrer, J.P. Ponder, B.A.J. Sangrajrang, S. |
2008-04-01
|
|
Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial
(Article)
Schalm, S.W. Heathcote, J. Cianciara, J. Farrell, G. Sherman, M. Willems, B. Dhillon, A. Moorat, A. Barber, J. Gray, D.F. |
2000-01-01
|
